Drooid Logo
Back to story perspectives

Full Breakdown

Inquest Reveals Influence of Conspiracy Theorist Mother in Daughter's Death

10/3/2025, 1:46:37 AM

Coroner's Findings on Paloma Shemirani's Death

Paloma Shemirani, a 23-year-old woman, died in July 2024 after refusing chemotherapy for non-Hodgkin lymphoma, a decision the coroner attributed to the "adverse influence" of her mother, Kay Shemirani, a prominent conspiracy theorist. The inquest, held at Kent and Medway Coroner's Court, concluded that Kay's actions "more than minimally" contributed to Paloma's death, which could have been prevented with conventional treatment.

Paloma was diagnosed in December 2023 and was initially told by doctors at Maidstone Hospital that she had an 80% chance of recovery if she underwent chemotherapy. However, after moving back in with her mother, who had been estranged from her prior to the diagnosis, Paloma opted for alternative treatments, including daily coffee enemas and a strict diet. The coroner, Catherine Wood, stated that if Paloma had been encouraged to accept her diagnosis and consider chemotherapy with an open mind, she likely would have chosen to pursue the treatment.

Background on Kay Shemirani's Influence

Kay Shemirani, known for her anti-vaccine views, was struck off as a nurse in 2021 for spreading misinformation that posed a risk to public health. During the inquest, it was revealed that she played a significant role in advising Paloma on alternative treatments, which included questioning the validity of conventional medical advice. The coroner noted that Kay's influence was so profound that it "seeded doubt" in Paloma's mind regarding her diagnosis.

Paloma's twin brother, Gabriel Shemirani, expressed his belief that their mother "sacrificed" Paloma for her own principles, stating, "I blame my mother entirely for my sister's death." He described a family dynamic marked by dysfunction and alleged emotional and physical abuse, which he claimed contributed to Paloma's decision to reject medical treatment.

Medical Perspectives and Family Dynamics

Medical professionals who treated Paloma expressed concern over her mother's influence. Arunodaya Mohan, a consultant haematologist, noted that Paloma had initially considered chemotherapy but completely dismissed it after her discharge from the hospital. An osteopath who assessed Paloma on the day she collapsed remarked that he had "never seen" a lymphoid mass like hers in his 43 years of practice, indicating the severity of her condition.

Despite the coroner's findings, Kay Shemirani attempted to shift blame onto medical staff, claiming that her daughter's death resulted from "gross negligence manslaughter" by healthcare providers. However, the inquest concluded that medical staff acted appropriately throughout Paloma's treatment.

Official Statements and Responses

Coroner Catherine Wood stated, “If approached with an open mind, Paloma would have chosen the chance to survive, and if she had undergone chemotherapy, she probably would have survived.” She described Kay Shemirani's care of her daughter as "incomprehensible" and noted the striking dysfunction within the Shemirani family, which was evident during the inquest proceedings.

Gabriel Shemirani criticized the state for not classifying his sister's death as an unlawful killing, despite acknowledging a breach in their mother's duty of care. He stated, “It pains me to say that this is a failure by the state... by social services who played a blind eye to the abuse it should have exposed.”

Verbatim Quotes

  • “It seems that if Paloma had been supported and encouraged to accept her diagnosis and considered chemotherapy with an open mind she probably would have followed that course.” — Catherine Wood, Coroner
  • “I blame my mother entirely for my sister’s death” — Gabriel Shemirani, Brother

The inquest into Paloma Shemirani's death highlights the complex interplay between family influence and medical decision-making, raising critical questions about the responsibilities of caregivers and the impact of misinformation on health outcomes.